News | June 05, 2014

Lasers and Night-Vision Technology Help Improve Imaging of Hidden Lymphatic System

UTHealth researchers’ new device, NIRFLI, may allow doctors to sooner detect and better manage cancer therapy and lymphedema

Still image illustrating the lack of lymphatic flow in the lower leg of a subject with lymphedema. Credit: John Rasmussen

June 5, 2014 — A team of researchers at the University of Texas Health Science Center at Houston (UTHealth) Medical School has developed a new technology that can noninvasively image the human lymphatic system (also known as “lymphatics”). A fluorescent dye and commercially available laser diode and military-grade night vision devices were used to visualize the lymphatic capillaries.

The human lymphatic system is an important but poorly understood circulatory system consisting of tiny vessels spread throughout the body. This “drainage” network helps guard against infections and prevents swelling, which occasionally happens when disease or trauma interrupts normal lymphatic function. Chronic swelling is the hallmark of a painful, incurable condition known as lymphedema, which often occurs after cancer therapy and can leave the limbs and other body parts disfigured for life. Detecting lymphedema early, before swelling occurs, would lead to better outcomes for patients, but the major barrier preventing early diagnosis is the lack of high-resolution imaging techniques that can resolve these tiny vessels.

Clinically, the UTHealth researchers’ device promises improvements in patient care because it allows even tiny lymph vessels to be imaged, and it can quantitatively measure fluid flow throughout the lymphatic system — two types of measurements that are impossible with current technology.

At Conference on Lasers and Electro-Optics (CLEO) 2014, to be held June 8-13 in San Jose, Calif., UTHealth scientist John Rasmussen, Ph.D., will describe how they have taken this technology, which they call near-infrared fluorescence lymphatic imaging (NIRFLI), from bench-top development to various clinical applications. "We feel that the ability to see the lymphatics will provide opportunities to revolutionize lymphatic care," Rasmussen said.

The major problem with lymphatic imaging is that the small lymphatic vessels are filled with lymph, a clear liquid that lacks the natural contrast needed to show up on modalities like computer tomography (CT) or magnetic resonance imaging (MRI). While one might think about injecting dyes or other contrast "agents" into the lymphatic vessels to make them more visible, the vessels are very difficult to find and are most often too small to insert a needle.

An existing technology, called lymphoscintigraphy, can take images of the lymphatic system following injection of a radioactive compound into or below the skin. However, lymphoscintigraphy typically takes 20 to 45 minutes to acquire a single grainy picture, and can only image the largest lymphatic vessels or trunks. The smaller vessels, which make up the bulk of the lymphatic system, are invisible to lymphoscintigraphy. In addition because of the long acquisition times, it cannot capture the real-time flow of fluid in the system.

At CLEO: 2014, Rasmussen will describe how NIRFLI allows lymphatic structures and flow to be measured quantitatively, including in the fine vessels — an improvement over lymphoscintigraphy. In addition, NIRFLI will be safer and less expensive than existing technology.

To acquire images of the lymphatics, NIRFLI uses indocyanine green dye, which is injected in tiny amounts into the skin of a patient. The dye is absorbed into the lymphatics and when illuminated by the laser diode, it emits a fluorescent light, which the device amplifies with a military-grade image intensifier (the main component in night vision goggles) and then captures with a commercial CCD digital camera.

The image intensifier enables the small lymphatic vessels to be visualized, and by taking sequences of such images, they can produce movies showing flow within the lymphatics. Rasmussen said that the most immediate promise of NIRFLI will be to diagnose and monitor the treatment of lymphedema and may also help surgeons identify and remove lymph nodes into which cancer tumors drain.

"From these images and movies, we can identify abnormal lymphatic structure and function in a variety of diseases and disorders in which the lymphatics play a role," Rasmussen said. "I think we have barely scratched the surface of what is possible."

NIRFLI was developed with funding from the U.S. National Institutes of Health and in collaboration with Eva Sevick-Muraca, Ph.D., and other scientists and engineers at UTHealth. Rasmussen added that UTHealth has licensed the technology to NIRF Imaging Inc. for commercialization.

For more information: www.cleoconference.org

Related Content

Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA. Photo by Dave Fornell.

Brain images that have been pre-reviewed by the Viz.AI artificial intelligence software to identify a stroke. The software automatically sends and alert to the attending physician's smartphone with links to the imaging for a final human assessment to help speed the time to diagnosis and treatment. Depending on the type of stroke, quick action is needed to either activate the neuro-interventional lab or to administer tPA. Photo by Dave Fornell.

Feature | Artificial Intelligence | May 17, 2019 | Inga Shugalo
With its increasing role in medical imaging,...
Videos | Advanced Visualization | May 16, 2019
This is an example of how virtual reality is being used in neuro-radiology to better evaluate patients using advanced
he DigitalDiagnost C90 is Philips newest premium digital radiography (DR) system, introduced here at the Radiological Society of North America (RSNA) 2018 meeting. It is the industry’s first radiography unit with a live camera image directly displayed at the tube head to provide a clear view of the anatomical area being scanned during the patient positioning process.
360 Photos | 360 View Photos | May 08, 2019
The DigitalDiagnost C90 is Philips newest premium ...
Artificial intelligence (AI) was again the hottest topic in radiology, with 11 of the top 20 pieces of content this month relating to AI. These images are a few of the AI technologies highlighted in ITN Editor's Choice video of the most innovative AI technologies highlighted at RSNA 2018.

Artificial intelligence (AI) was again the hottest topic in radiology, with 11 of the top 20 pieces of content this month relating to AI. These images are a few of the AI technologies highlighted in ITN Editor's Choice video of the most innovative AI technologies highlighted at RSNA 2018. 

Feature | May 01, 2019
May 1, 2019 — Here is the list of the most popular content on the Imaging Technology New (ITN) magazine webs
Videos | RSNA | April 03, 2019
ITN Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies displa
Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill. Interview with Mark Pankuch, Ph.D.

Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill.
 

Feature | April 02, 2019 | Dave Fornell, Editor and A.J. Connell
April 2, 2019 — Here is the list of the most popular content on the Imaging Technology News (ITN) magazine w
At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve).

At #ACC.19, Siemens unveiled a version of its go.Top platform optimized for cardiovascular imaging. The newly packaged scanner can generate the data needed to do CT-based FFR (fractional flow reserve). Photo by Greg Freiherr

Feature | Cardiac Imaging | March 22, 2019 | By Greg Freiherr
Reflecting a trend toward the increased use of...